Red light therapy has been found to enhance optic nerve function by improving the efficiency of energy production in the mitochondria of retinal cells. By stimulating the activity of mitochondria, red light therapy can improve the production of adenosine triphosphate (ATP), the energy currency of cells. This increased energy production can improve the overall function of the optic nerve cells, leading to improved vision.

V20 light therapy device is eligible for all ages of patients from young kids to seniors over 80 years old. This non-invasive device offers not only red light, but also multispectral light and syntonic light. You can get three different kinds of light therapy by using one device.

AC STIM is eligible for treating optic nerve damage caused by glaucoma, injury, ischemic optic neuropathy, optic neuritis, papilledema, brain tumor or the retinal disorders. In order to optimize the treatment results, AC STIM, plus StemActiv, represents the best combination of treatment to get the best results. The device stimulates the optic nerve from outside and StemActiv activates the dormant optic nerve cells from inside. The combination offers the strongest effects.

Ocular iontophoresis is a non-invasive and safe method for driving drug-loaded nanoparticles, including medicine ions and charged macromolecules, into the anterior and posterior segments of the eye. It has the following effects:

· anti-inflammation and maintenance of the optimal ocular microbiome

· dilation of blood vessels in the eyes and facilitating repair of the ocular vascular system

· improvement of blood flow to the retina and increased oxygen and nutrients in the retina

· reduced eye fatigue

· improved central vision acuity

· expansion of peripheral vision

· improved night vision